Studies show that people taking semaglutide can lose around 15% of their body weight, and people taking tirzepatide can lose more than 20%
Final Thoughts: Build a Repeatable Shot-Day System Shot day gets easier when you stop treating it like a normal day
Yet with preclinical trials ongoing, the list of insurance-approved uses could soon expand to include sleep apnea (which can be weight-related), Parkinsons, dementia, and more
A person eating 1,000 to 1,400 calories on GLP-1 has almost no margin at all
In muscle tissue of aged mice, lowered level of pro-inflammatory markers IL-1, TNF-, and IL-6 was observed after GLP-1RA dulaglutide treatment (Khin et al., 2021
Clinical trial data have produced mixed findings that require careful interpretation